健康な小児の骨髄の単細胞マルチオームアトラスは,ストロマルシグナル伝達によって引き起こされる系統の差別化における年齢依存の違いを明らかにしています
Evelyn S Hanemaaijer1, Konradin F Müskens1, Ireen J Kal1
1Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Nature immunology
|February 17, 2026
まとめ
人間の骨髄の組成は,幼児期から青年期まで大きく変化します. この研究は,血液形成幹細胞および前身細胞 (HSPC) およびその微環境における年齢依存のシフトを明らかにし,血液細胞の発達に影響を与えています.
科学分野:
- 血液学 ヘマトロジ
- 発達生物学 発達生物学について
- 免疫学 免疫学とは
背景:
- 幼児期は,血液細胞の発達にとって極めて重要な時期であり,血液学的疾患に対する高い感受性の時期である.
- 血液形成の正常な発達を理解することは,幼児期の血液疾患の起源を特定する上で鍵となるものです.
研究 の 目的:
- 発達段階を超えた健康なヒトの骨髄の包括的な単細胞アトラスを作成する.
- 幼児期から若年成人期までの骨髄の年齢依存の組成と分子差異を調査する.
- 造血幹細胞と原始細胞 (HSPC) の系統の可能性を調節する骨髄のマイクロ環境の役割を調査する.
主な方法:
- 骨髄細胞90,710のマルチモダル単細胞アトラスを生成し,mRNAと表面タンパク質発現を分析した.
- 9人のドナー (年齢2〜32歳) の20,000以上の血液形成性幹細胞と前身細胞 (HSPC) とメゼンキマ・ストロマル細胞 (MSC) を含む.
- 6つの骨髄生検 (年齢0~23歳) で空間トランスクリプトミクスを利用し,年齢関連の変化を確認しました.
主要な成果:
- 若い小児 (YP,<10歳) と青少年/若年成人 (AYA,≥13歳) の骨髄の間の異なる組成および分子プロファイルが特定されました.
- YPにおけるB細胞優位性からAYAにおけるミエロイドおよびT細胞バイアスへの血液生成出力のシフトが観察されました.
- 2つの異なるリンパ性原始体 (LyP) のサブセット (CD127+とCD127-) を発見し,年齢依存の系統シフトを調節した.
- YP骨髄におけるMSCによるIL-7の生産の増加を含む,年齢依存のストロマルシグナル伝達の変化が見つかりました.
結論:
- 人間の骨髄は,幼児期から若年成人期まで,重要な発達変化を経験します.
- これらの変化は,異なるHSPC集団とそれらのニッチの相互作用を伴うもので,特にMSC由来IL-7によって媒介される.
- 作成されたアトラスは,正常な血液形成と血液学的疾患の初期起源を理解するための重要なリソースとなります.
さらに関連する動画
関連する概念動画
Lineage Commitment
4.4K
Commitment is the process whereby stem cells:
4.4K
Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
Hematopoiesis
9.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.2K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
4.5K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.5K
Multipotency of Hematopoietic Stem Cells
3.9K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.9K
Bone Marrow Sampling and Transplants
1.5K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.5K


